Advertisement
Advertisement

TEVA

TEVA logo

Teva Pharmaceutical Industries Limited - ADR

36.25
USD
Sponsored
+0.73
+2.06%
Feb 03, 15:59 UTC -5
Closed
exchange

After-Market

36.35

+0.10
+0.27%

TEVA Earnings Reports

Positive Surprise Ratio

TEVA beat 14 of 29 last estimates.

48%

Next Report

Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$3.90B
/
$0.51
Implied change from Q4 25 (Revenue/ EPS)
-17.20%
/
-46.88%
Implied change from Q1 25 (Revenue/ EPS)
+0.24%
/
-1.92%

Teva Pharmaceutical Industries Limited - ADR earnings per share and revenue

On Jan 28, 2026, TEVA reported earnings of 0.96 USD per share (EPS) for Q4 25, beating the estimate of 0.69 USD, resulting in a 38.55% surprise. Revenue reached 4.71 billion, compared to an expected 4.46 billion, with a 5.74% difference. The market reacted with a +2.09% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 0.51 USD, with revenue projected to reach 3.90 billion USD, implying an decrease of -46.88% EPS, and decrease of -17.20% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Dr. Reddy's Laboratories Limited - ADR
Report Date
Jan 21, 2026 For Q3 26
Estimate
$13.86
Actual
$14.52
Surprise
+4.69%
FAQ
For Q4 2025, Teva Pharmaceutical Industries Limited - ADR reported EPS of $0.96, beating estimates by 38.55%, and revenue of $4.71B, 5.74% above expectations.
The stock price moved up 2.09%, changed from $32.53 before the earnings release to $33.21 the day after.
The next earning report is scheduled for May 05, 2026.
Based on 4 analysts, Teva Pharmaceutical Industries Limited - ADR is expected to report EPS of $0.51 and revenue of $3.90B for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement